Please Wait

Applying Filters...

Promoted Content

Promoted Content

X

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Prices
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Container Closure Integrity Testing (CCIT) is an assay that evaluates the adequacy of container closure systems to maintain a sterile barrier against potential contaminants. Contaminants that could potentially cross a container closure barrier include microorganisms, reactive gases, and other substances (USP <1207>). Container closure systems should maintain the sterility and product quality of sterile final pharmaceutical, biological, and vaccine products throughout their shelf-life. Container

proveris-scientific-Default-Wallpaper

proveris-scientific-Default-Wallpaper

Filters

×

FILTER DATA :

Company

All

Curia

Country

All

UNITED STATES

Curia

A partner for the pharma and biotech industries to improve patient outcomes & quality of life

United States

Contact Supplier

CPhI Japan 2022

Booth # 1H-9

Request a Meeting Now

Residual Seal Force (RSF)

Supporting Information: Click here to upload a PDF

Link to Supplier Content

Contact the Supplier

Curia-Residual-Seal-Force-(RSF)

- Service Details

Curia's expert team offers parenteral vial capping and residual seal force (RSF) testing of parenteral package systems.

- Directory Listing

Pharma Service: Analytical

Category: Container Closure Integrity

Sub Category: Residual Seal Force (RSF)

Market Place

Home

Menu

Post Enquiry

Market Place

Search